ATI Hematologic Pharmacology Exam

. Edema: A healthcare professional is caring for a patient who has mild hemo- philia A and is about to begin taking desmopressin DDAVP to prevent bleeding the healthcare professional should monitor for which of the following adverse reactions? 2.Aminocaproic acid (Amicar): A healthcare professional is caring for a patient who is about to begin alteplase (Activase) therapy to treat pulmonary embolism. Which of the following drugs should the healthcare professional have available in the event of a severe adverse reaction? 3. Inhibiting cyclooxygenase action in platelets: A healthcare professional is caring for a patient who is about to begin taking aspirin (Ecotrin) to reduce the risk of a cardiovascular event.The healthcare professional should understand that the drug inhibits platelet aggregation by which of the following mechanisms? 4. Increases platelet production: A healthcare professional is caring for a patient who is about to begin taking oprelvekin (Neumega).The healthcare professional should explain to the patient that they drug has which of the following effects? 5. Clarify the prescriptionwith the provider.: Ihealthcare professional is prepar- ing to administer the prescribed dose of filgrastim (Neupogen) to a patient.The patient's laboratory results indicate that the patient has a white blood count of 12,000 mm3 of the following actions should the healthcare professional tonight? 6. Eat are rich foods. Spread the dosage across each day.Take the drug on an empty stomach. Increase dietary fiber intake.: A healthcare professional is caring for a patient who is about to begin taking ferrous sulfate (Feosol) to treat iron-deficiency anemia. When talking with the patient about the drug, the healthcare professionalshould include which of the following instructions? (Select all that apply.) 7.Administer a test dose. Monitor blood pressure. Have epinephrine avail- able.Use the Z-track technique.: A healthcare professional is caring for a patient who is about to begin iron dextran (INFed) therapy.When administering the drug IM, the healthcare professionalshould take which of the following actions? (Select all that apply.) 8. Creutzfeldt-Jakob disease: A patient is about to begin therapy with recombi- nant factor IX (BeneFix) to treat hemophilia B.The patient asks the health care professional about the risk of disease transmission with recombinant factor IX, as compared with plasma-derived factor IX.The health care professional should explain that recombinant factor IX illuminates the risk for which of the following? 9.Headache: A healthcare professional is caring for a patient who is about to begin alteplase (Activase) therapy.The health care professional should monitor the patient for which of the following indications of the possible adverse effect? 10.Hgb: A healthcare professional is caring for a patient who is about to begin taking epoetin alfa (Epogen). Which of the following laboratory values should increase with effective therapy? 11.Conjunctivitis.Swollen ankles.Palpitations.: Ahealthcare professional ask- ing for a patient who is about to begin taking oprelvekin (Neumega) to treat thrombocytopenia.The healthcare professional should tell the patient to report which of the following indications of an adverse reaction? (Select all that apply.) 12.Deferoxamine (Desferal): A patient who is taking ferrous sulfate (Feosol) to treat iron-deficiency anemia develop severe nausea and vomiting due to iron toxicity.Which of the following drugs should a healthcare professional use to treat this complication? 13. Vitamin K: A patient who is taking warfarin (Coumadin) arrives to the emer- gency department and reports rectal bleeding.Which ofthe following drugsshould healthcare professional have available? 14. Vitamin B 12: A healthcare professional should assess a patient who has megaloblastic anemia for indications of which ofthe following vitamin deficiencies? 15. Peptic ulcer disease: A healthcare professional is caring for a patient who is about to begin taking (Plavix) to prevent thrombus formation.The healthcare professional should question the use of clopidogrel by a patient who has which of the following?